Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4249593
Max Phase: Preclinical
Molecular Formula: C56H90N12O19S
Molecular Weight: 1267.47
Molecule Type: Small molecule
Associated Items:
ID: ALA4249593
Max Phase: Preclinical
Molecular Formula: C56H90N12O19S
Molecular Weight: 1267.47
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
Standard InChI: InChI=1S/C56H90N12O19S/c1-28(2)24-38(66-54(84)41(27-42(59)70)64-47(77)33(58)15-18-43(71)72)51(81)61-36(21-23-88-7)50(80)68-46(30(5)6)55(85)62-35(17-20-45(75)76)48(78)60-34(16-19-44(73)74)49(79)67-40(26-31-11-13-32(69)14-12-31)53(83)65-39(25-29(3)4)52(82)63-37(56(86)87)10-8-9-22-57/h11-14,28-30,33-41,46,69H,8-10,15-27,57-58H2,1-7H3,(H2,59,70)(H,60,78)(H,61,81)(H,62,85)(H,63,82)(H,64,77)(H,65,83)(H,66,84)(H,67,79)(H,68,80)(H,71,72)(H,73,74)(H,75,76)(H,86,87)/t33-,34-,35-,36-,37-,38-,39-,40-,41-,46-/m0/s1
Standard InChI Key: OPQNAYQXOPPIQF-MIYYYOSJSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1267.47 | Molecular Weight (Monoisotopic): 1266.6166 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Ebner S, Trieb M, Schönfeld M, Wietzorrek G, Santos-Sierra S.. (2018) Decoy peptides derived from the extracellular domain of toll-like receptor 2 (TLR2) show anti-inflammatory properties., 26 (16): [PMID:30093346] [10.1016/j.bmc.2018.07.013] |
Source(1):